Increased neopterin in patients with chronic and acute coronary syndromes

Journal of the American College of Cardiology

Volumn 30, Issue 3, 1997, Pages 703-707

  Schumacher, Martin ^a   Halwachs, Gabriele ^a   Tatzber, Franz ^a   Fruhwald, Friedrich M ^a   Zweiker, Robert ^a   Watzinger, Norbert ^a   Eber, Bernd ^a   Wilders Truschnig, Martie ^a   Esterbauer, Hermann ^a   Klein, Werner ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NEOPTERIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX PAIN;

EID: 0030983843     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00172-1     Document Type: Review

References (25)

1. Fuster V, Badimon L, Badimon J, Chesbro JH. Mechanisms of disease I - the pathogenesis of coronary artery disease and the acute coronary syndromes . N Engl J Med. 326:1992;242-250.
2. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes implications for plaque rupture . Circulation. 90:1994;775-778.
3. Welgus HG, Campbell EJ, Cury JD, et al. Neutral metalloproteinases produced by human mononuclear phagocytes. J Clin Invest. 86:1990;1496-1502.
4. Wachter H, Fuchs D, Hausen A, et al. Neopterin Biochemistry-Methods - Clinical Application . 1992;DeGruyter, Berlin.
5. Tatzber F, Rabl H, Koriska K, et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis. 89:1991;203-208.
6. Weiss G, Willeit J, Kiechl S, et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis. 106:1994;263-271.
7. Melichar B, Gregor J, Solochova D, Lukes J, Tichy M, Pidrman V. Increased urinary neopterin in acute myocardial infarction. Clin Chem. 40:1994;338-339.
8. Neuhaus K-L, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol. 14:1989;1566-1569.
9. Schumacher M, Eber B, Tatzber F, Kaufmann P, Esterbauer H, Klein W. Neopterin levels in patients with coronary artery disease. Atherosclerosis. 94:1992;87-88.
10. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 85:1990;1260-1266.
11. Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature. 344:1990;254-257.
12. Cruickshank AM, Oldroyd KG, Cobbe SM. Serum interleukin-6 levels in suspected myocardial infarction. Lancet. 343:1994;974.
13. Miyao Y, Yasue H, Ogawa H, et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304.
14. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 65:1990;168-172.
15. Andreotti F, Roncaglioni MC, Hackett DR, et al. Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction. J Am Coll Cardiol. 16:1990;1552-1560.
16. De Beer FC, Hind CRK, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in acute myocardial infarction. Br Heart J. 42:1982;239-243.
17. Maury CPJ, Tötterman KJ, Gref C-G, Ehnholm C. Serum amyloid A protein, apolipoprotein A-I and apolipoprotein B during the course of acute myocardial infarction. J Clin Pathol. 41:1988;1263-1268.
18. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
19. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 146:1995;419-428.
20. Lissoni P, Pellizoni F, Mauri O, Perego M, Pittalis S, Barni S. Enhanced secretion of tumor necrosis factor in patients with myocardial infarction. Eur J Med. 1:1992;277-280.
21. Kojima S, Icho T, Kajiwara Y, Kubota K. Neopterin as an endogenous antioxidant. FEBS Lett. 304:1992;163-166.
22. Baier-Bitterlich G, Fuchs D, Murr D, et al. Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor-α induced programmed cell death. FEBS Lett. 364:1995;234-238.
23. Gieseg SP, Reibnegger G, Wachter H, Esterbauer H. 7,8-Dihydroneopterin inhibits low-density-lipoprotein oxidation in-vitro - evidence that this macrophage secreted pteridine is an antioxidant. Free Radic Res. 23:1995;123-126.
24. Antman EM, Braunwald E. Acute myocardial infarction. Braunwald E. Heart Disease. 5th ed. 1997;1184-1288 WB Saunders, Philadelphia.
25. Agostoni A, Gardinali M, Frangi D, et al. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction a comparison between streptokinase and recombinant tissue-type plasminogen activator . Circulation. 90:1994;2666-2670.